medigraphic.com
ISSN 1561-3046 (Electronic)

2020, Number 4

<< Back Next >>

Rev Cub Med Mil 2020; 49 (4)

Predictors of poor prognosis in patients with COVID-19

González TR, Acosta GFA, Oliva VE, Rodríguez RSF, Cabeza EI

Language: Spanish
References: 23
Page:
PDF size: 272.68 Kb.


ABSTRACT

Introduction: COVID-19 has been characterized by a wide spectrum of manifestations and clinical forms that range from mild illness to death. Identifying those most likely to develop complications is critical.
Objective: To identify risk factors for developing complications in patients treated with COVID-19.
Methods: 250 medical records of patients admitted for COVID-19 were reviewed. Age, sex, personal pathological history, laboratory tests and the presence or absence of complications were collected. Chi-square was used to identify the relationship between complications and sex. The Odds Ratio (OR) was calculated for complications by age groups, personal pathological history, and humoral parameters.
Results: Respiratory distress was more frequent in men (p=0.023). The most affected age groups were 60 to 79 years and 80 years and over (OR=4.85 and 30.53 respectively). Risk factors were the history of arterial hypertension, ischemic heart disease, diabetes mellitus, chronic kidney insufficiency and dementia (OR=4.48, 4.22, 8.75, 17.98 and 10.39 respectively). Low hematocrit and lymphocytes were predisposed to complications, as well as high neutrophils, glycaemia, creatinine, ASAT, GGT and LDH.
Conclusions: The highest risk of complications was in patients older than 60 years, with cardiovascular diseases, diabetes mellitus, kidney insufficiency and dementia. The presence of low hematocrit and lymphocytes, or high neutrophils, glycaemia, creatinine, ASAT, GGT and LDH, alerts you to possible complications.


REFERENCES

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020 [acceso: 17/08/2020]; 382(8):727-33. Disponible en: Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa2001017

  2. Adhanom T. Intervención del Director General de la OMS en la conferencia de prensa sobre el 2019-nCoV del 11 de febrero de 2020. Ginebra: OMS; 2020. [acceso: 17/08/2020]. Disponible en: Disponible en: https://www.who.int/es/dg/speeches/detail/Who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

  3. Zhang SY, Lian JS, Hu JH, Zhang XL, Lu YF, Cai H, et al. Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China. Infectious diseases of poverty. 2020[acceso: 17/08/2020]; 9(1):10p. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087732326&doi=10.1186%2fs40249-020-00710-6&partnerID=40&md5=affb07616d30aee3cb018b5390fdeb87

  4. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard 2020. [actualizado 2020/8/17; acceso: 17/08/2020 ]. Disponible en: Disponible en: https://covid19.who.int/?gclid=EAIaIQobChMI99fZpbKi6wIV9f3jBx3mlAk7EAAYASAAEgLSX_D_BwE

  5. Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetology and Metabolic Syndrome. 2020[acceso: 17/08/2020]; 12(1):11p. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088011066&doi=10.1186%2fs13098-020-00565-9&partnerID=40&md5=8b932cc30dcc834e426208ebc16f8e05

  6. Hou W, Zhang W, Jin R, Liang L, Xu B, Hu Z. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infectious Diseases. 2020[acceso: 17/08/2020]; 52(7):498-505. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084347301&doi=10.1080%2f23744235.2020.1759817&partnerID=40&md5=8e1ea0c09e1b55bf6923e35e7c0aac47

  7. Zhu S, Tao J, Gao H, He D. Age, source, and future risk of COVID-19 infections in two settings of Hong Kong and Singapore. BMC research notes. 2020 [acceso: 17/08/2020]; 13(1):3p. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088021697&doi=10.1186%2fs13104-020-05178-z&partnerID=40&md5=df704fa9c61290894e48f65833085f05

  8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020[acceso: 17/08/2020]; 395(10229):1054-62. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081901579&doi=10.1016%2fS0140-6736%2820%2930566-3&partnerID=40&md5=60b48cc828061e7b65a326e43414171d

  9. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al . Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine. 2020[acceso: 17/08/2020]; 180(7):934-43. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081683293&doi=10.1001%2fjamainternmed.2020.0994&partnerID=40&md5=ac099e7fdae821edd1a7983519bc6fc4

  10. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020[acceso: 17/08/2020]; 5(7):811-18. Disponible en: Disponible en: https://doi.org/10.1001/jamacardio.2020.1017

  11. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology. 2020[acceso: 17/08/2020]; 5(7):802-10. Disponible en: Disponible en: https://doi.org/10.1001/jamacardio.2020.0950

  12. Xu J, Yang X, Yang L, Zou X, Wang Y, Wu Y, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: A multicenter retrospective study from Wuhan, China. Critical Care. 2020[acceso: 17/08/2020]; 24(1):11p. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087663356&doi=10.1186%2fs13054-020-03098-9&partnerID=40&md5=a5ac00dd1b932c9d5c815961e6114e89

  13. Bess Constantén S, Alonso Alomá I, Sánchez Sordo E, Martínez Morales MÁ, López Nistal LM, Alonso Expósito I, et al. Anuario Estadístico de Salud 2019. La Habana Ministerio de Salud Pública Dirección de Registros Médicos y Estadísticas de Salud; 2020. Disponible en: http://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf

  14. Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al . Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study. Diabetes Research and Clinical Practice. 2020[acceso: 17/08/2020]; 8p. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085763427&doi=10.1016%2fj.diabres.2020.108227&partnerID=40&md5=ae17ce73d1687129b84e48659620a479

  15. Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al . Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020[acceso: 17/08/2020]; 43(7):1382-91. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086792869&doi=10.2337%2fdc20-0598&partnerID=40&md5=98144d1b276222d9d667cffb3e501b90

  16. Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, et al . Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020[acceso: 17/08/2020]; 43(7):1399-407. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086089021&doi=10.2337%2fdc20-0660&partnerID=40&md5=057a60ad986eea195342a5b37716c79b

  17. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. The Journal of clinical endocrinology and metabolism. 2020[acceso: 17/08/2020]; 105(8):10p . Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087530202&doi=10.1210%2fclinem%2fdgaa346&partnerID=40&md5=f26b0bc716ff2c4e6c867ebeb5a01cab

  18. Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system. American journal of physiology Regulatory, integrative and comparative physiology. 2018[acceso: 17/08/2020]; 315(5):895-906. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295500/

  19. Underner M, Peiffer G, Perriot J, Jaafari N. Smoking and coronavirus disease 2019 (COVID-19). Rev Mal Respir. 2020[acceso: 17/08/2020]; 37(5):433-6. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141481/

  20. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International urology and nephrology. 2020[acceso: 17/08/2020]; 52(6):1193-4. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103107/

  21. Ding X, Yu Y, Lu B, Huo J, Chen M, Kang Y, et al . Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019. Clinical chemistry and laboratory medicine. 2020[acceso: 17/08/2020]; 58(8):1365-71. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085648159&doi=10.1515%2fcclm-2020-0411&partnerID=40&md5=38ff22ce164e207adaa90b66758ab62f

  22. Bonetti G, Manelli F, Patroni A, Bettinardi A, Borrelli G, Fiordalisi G, et al . Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy. Clinical chemistry and laboratory medicine. 2020[acceso: 17/08/2020]; 58(7):1100-5. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084800047&doi=10.1515%2fcclm-2020-0459&partnerID=40&md5=a213f3efe02b6cbbcb611b3f885a47d4

  23. Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al . D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. Journal of Intensive Care. 2020[acceso: 17/08/2020]; 8(1):11p. Disponible en: Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088020747&doi=10.1186%2fs40560-020-00466-z&partnerID=40&md5=c5090eaa41aa142afba068c05e179c4c




2020     |     www.medigraphic.com